Advertisement

Jehovah’s Witnesses

  • Shobana Chandrasekhar
Chapter

Abstract

Pregnant patients who are Jehovah’s witnesses pose a number of clinical and ethical concerns. Their management includes careful preoperative evaluation and documentation regarding acceptability of blood-derived plasma or cellular components and blood conservation techniques. Anesthetic management includes discussing and clearly understanding patient’s wishes regarding refusal of blood and blood products even under life-threatening circumstances.

Keywords

Obstetric hemorrhage Jehovah’s witness Maternal fetal conflict Normovolemic hemodilution Cell saver device 

References

  1. 1.
    Singla AK, Lapinski RH, Berkowitz RL, Saphier CJ. Are women who are Jehovah’s witness at risk of maternal death? Am J Obstet Gynecol. 2001;185(4):893–5.CrossRefGoogle Scholar
  2. 2.
    Broaddus B, Chandrasekhar S. Informed consent in obstetric anesthesia. Anesth Analg. 2011;112(4):912–5.CrossRefGoogle Scholar
  3. 3.
    Oddi AS. The tort of interference with the right to die: the wrongful living cause of action. Georgetown Law J. 1986;75:625.PubMedGoogle Scholar
  4. 4.
    Beholz S, Liu J, Thoelke R, Spiess C, Konertz W. Use of desmopressin and erythropoietin in an anemic Jehovah’s witness patient with severely impaired coagulation capacity undergoing stentless aortic valve replacement. Perfusion. 2001;16:485–9.CrossRefGoogle Scholar
  5. 5.
    Belfort M, Kofford S, Varner M. Massive obstetric hemorrhage in a Jehovah’s witness: intraoperative strategies and high dose erythropoietin use. Am J Perinatol. 2011;28:207–10.CrossRefGoogle Scholar
  6. 6.
    Sienas L, Wong T, Collins R, Smith J. Contemporary uses of erythropoietin in pregnancy: a literature review. Obstet Gynecol Surv. 2013;68:594–602.CrossRefGoogle Scholar
  7. 7.
    Nagy CJ, Wheler AS, Archer TL. Acute normovolemic hemodilution, intraoperative cell salvage, and Pulse CO hemodynamic monitoring in a Jehovah’s witness with placenta accrete. Int J Obstet Anesth. 2008;17:159–63.CrossRefGoogle Scholar
  8. 8.
    Liumbruno GM, Meschini A, Liumbruno C, Rafanelli D. The introduction of intra-operative cell salvage in obstetric clinical practice: a review of the available evidence. Eur J Obstet Gynecol Reprod Biol. 2011;159:19–25.CrossRefGoogle Scholar
  9. 9.
    Ralph CJ, Sullivan I, Faulds J. Intraoperative cell salvaged blood as part of a blood conservation strategy in cesarean section: is fetal red cell contamination important? Br J Anaesth. 2011;107:404–8.CrossRefGoogle Scholar
  10. 10.
    Shahid A, Khan A. Tranexamic acid in decreasing blood loss during and after cesarean section. J Coll Physicians Surg Pak. 2013;23:459–62.PubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Shobana Chandrasekhar
    • 1
  1. 1.Department of AnesthesiologyBaylor Medical CenterHoustonUSA

Personalised recommendations